MapLight Therapeutics, Inc.(MPLT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MPLT MapLight Therapeutics, Inc.

未开盘 04-29 16:00:00 EDT

30.29

-0.02

-0.07%

盘后30.29

+0.000.00%

16:10 EDT

最高30.60	最低29.56	成交量20.12万
今开29.94	昨收30.31	日振幅3.43%
总市值12.85亿	流通市值4.47亿	总股本4,244万
成交额606.61万	换手率1.36%	流通股本1,475万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MPLT","market":"US","secType":"STK","nameCN":"MapLight Therapeutics, Inc.","latestPrice":30.29,"timestamp":1777492800000,"preClose":30.31,"halted":0,"volume":201220,"hourTrading":{"tag":"盘后","latestPrice":30.29,"preClose":30.29,"latestTime":"16:10 EDT","volume":607,"amount":18386.03,"timestamp":1777493405086,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0006598482349059576,"floatShares":14750000,"shares":42436300,"eps":-3.661,"marketStatus":"未开盘","change":-0.02,"latestTime":"04-29 16:00:00 EDT","open":29.94,"high":30.6,"low":29.56,"amount":6066125.049445,"amplitude":0.034312,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.661,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777536000000},"marketStatusCode":0,"adr":0,"listingDate":1761537600000,"exchange":"NASDAQ","adjPreClose":30.31,"preHourTrading":{"tag":"盘前","latestPrice":30,"preClose":30.31,"latestTime":"07:44 EDT","volume":50,"amount":1500,"timestamp":1777463085388,"change":-0.31,"changeRate":-0.010228,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":30.29,"preClose":30.29,"latestTime":"16:10 EDT","volume":607,"amount":18386.03,"timestamp":1777493405086,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.411437},"requestUrl":"/m/hq/s/MPLT","defaultTab":"news","newsList":[{"id":"2617552908","title":"Maplight Therapeutics, Inc.盘中异动 股价大涨5.11%报18.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617552908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617552908?lang=zh_cn&edition=full","pubTime":"2026-03-04 03:41","pubTimestamp":1772566875,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日03时41分，Maplight Therapeutics, Inc.股票出现波动，股价急速拉升5.11%。截至发稿，该股报18.50美元/股，成交量7.8101万股，换手率0.17%，振幅7.81%。Maplight Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.80%。其相关个股中，Edesa Biotech, Inc.、Onconetix, Inc.、Hcw Biologics Inc.涨幅较大，Edesa Biotech, Inc.、Onconetix, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为306.82%、199.87%、139.79%，振幅较大的相关个股有Edesa Biotech, Inc.、Onconetix, Inc.、Yd Bio Ltd C/Wts 28/08/2030，振幅分别为76.32%、47.82%、43.99%。Maplight Therapeutics, Inc.公司简介：malight Therapeutics是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304034115a447d7f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304034115a447d7f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","MPLT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606739773","title":"Maplight Therapeutics, Inc.盘中异动 快速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606739773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606739773?lang=zh_cn&edition=full","pubTime":"2026-01-28 00:41","pubTimestamp":1769532107,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日00时41分，Maplight Therapeutics, Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报18.89美元/股，成交量7.608万股，换手率0.17%，振幅6.34%。Maplight Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。其相关个股中，Biomx Inc.、Briacell Therapeutics Corp C/Wts 、Lisata Therapeutics, Inc.涨幅较大，Biomx Inc.、Vyome Holdings, Inc.、Genenta Science Spa较为活跃，换手率分别为2036.13%、748.47%、230.41%，振幅较大的相关个股有Biomx Inc.、Vyome Holdings, Inc.、Novabay Pharmaceuticals, Inc.，振幅分别为53.90%、39.87%、37.46%。Maplight Therapeutics, Inc.公司简介：malight Therapeutics是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128004148953e9a41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128004148953e9a41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MPLT","BK4539","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167154321","title":"MapLight Therapeutics阿尔茨海默病精神病药物ML-007C-MA获FDA快速通道认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1167154321","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167154321?lang=zh_cn&edition=full","pubTime":"2026-01-05 20:02","pubTimestamp":1767614544,"startTime":"0","endTime":"0","summary":"生物制药公司MapLight Therapeutics宣布，其针对阿尔茨海默病精神病症状的候选药物ML-007C-MA已获得美国食品药品监督管理局（FDA）授予的快速通道资格。这一认定将加速该药物的临床开发与审评进程，为患者提供更早获得创新疗法的可能。\nML-007C-MA是一种针对特定神经机制的新型治疗药物，旨在缓解阿尔茨海默病患者常见的精神病性症状，如幻觉、妄想和激越行为。快速通道资格的获得，意味着FDA认可该药物在未满足医疗需求领域的潜在价值，并将通过更频繁的沟通、滚动审评等机制支持其研发。\n公司表示将积极推进后续临床试验，力争早日为患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119775214","title":"MapLight获得合作化合物临床开发和商业化的独家权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1119775214","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119775214?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:06","pubTimestamp":1765886772,"startTime":"0","endTime":"0","summary":"MapLight获得合作化合物临床开发和商业化的独家权利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100462384","title":"Sandboxaq与MapLight Therapeutics宣布战略合作，共同研发新型中枢神经系统疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1100462384","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100462384?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:01","pubTimestamp":1765886484,"startTime":"0","endTime":"0","summary":"Sandboxaq与MapLight Therapeutics宣布战略合作，共同研发新型中枢神经系统疗法","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192124876","title":"MapLight Therapeutics, Inc.：Leerink Partners启动覆盖，评级为“跑赢大盘”；目标价30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192124876","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192124876?lang=zh_cn&edition=full","pubTime":"2025-11-21 20:17","pubTimestamp":1763727449,"startTime":"0","endTime":"0","summary":"MapLight Therapeutics, Inc.：Leerink Partners启动覆盖，评级为“跑赢大盘”；目标价30美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MPLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583580662","title":"Maplight Therapeutics, Inc.盘中异动 早盘大幅拉升6.70%报16.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583580662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583580662?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:34","pubTimestamp":1762958081,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时34分，Maplight Therapeutics, Inc.股票出现异动，股价大幅拉升6.70%。截至发稿，该股报16.08美元/股，成交量3256股，换手率0.01%，振幅0.00%。Maplight Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Salarius Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为4586.14%、304.64%、64.17%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.，振幅分别为46.48%、33.67%、14.86%。Maplight Therapeutics, Inc.公司简介：malight Therapeutics是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511122234419764f507&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511122234419764f507&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","MPLT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.maplightrx.com","stockEarnings":[{"period":"1week","weight":-0.0573},{"period":"1month","weight":0.6189},{"period":"3month","weight":0.6302},{"period":"6month","weight":0.7902},{"period":"1year","weight":0.7818},{"period":"ytd","weight":0.7245}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.126},{"period":"3month","weight":0.0253},{"period":"6month","weight":0.0433},{"period":"1year","weight":0.2837},{"period":"ytd","weight":0.0435}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MapLight Therapeutics, Inc.于2018年11月根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发中枢神经系统疾病的治疗方法。其主要候选药物ML-007C-MA是一种用于治疗精神分裂症和阿尔茨海默病精神病的固定剂量复方毒蕈碱激动剂，目前处于2期试验阶段。该公司还在开发用于治疗自闭症谱系障碍社交沟通障碍的ML-004。","exchange":"NASDAQ","name":"MapLight Therapeutics, Inc.","nameEN":"MapLight Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MapLight Therapeutics, Inc.(MPLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MapLight Therapeutics, Inc.(MPLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MapLight Therapeutics, Inc.,MPLT,MapLight Therapeutics, Inc.股票,MapLight Therapeutics, Inc.股票老虎,MapLight Therapeutics, Inc.股票老虎国际,MapLight Therapeutics, Inc.行情,MapLight Therapeutics, Inc.股票行情,MapLight Therapeutics, Inc.股价,MapLight Therapeutics, Inc.股市,MapLight Therapeutics, Inc.股票价格,MapLight Therapeutics, Inc.股票交易,MapLight Therapeutics, Inc.股票购买,MapLight Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MapLight Therapeutics, Inc.(MPLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MapLight Therapeutics, Inc.(MPLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}